Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum Objective: The aim of this study was to determine the association between three parameters of second trimester serum secreening and preterm labor and intrauterine growth restriction (IUGR) in patients with hyperemesis gravidarum (HG).
Gereç ve Yöntemler:
Bu prospektif çalışma hiperemezis gravidarumu olan 429 gebe üzerinde alfafetoprotein (AFP), unkonjuge estriol (uE3), human koryonik gonadotropin (HCG) ile preterm eylem, intrauterin gelişme geriliği arasındaki ilişkiyi belirlemek amacı ile dizayn edildi. 
Bulgular:

Introduction
A small percentage of women experience a severe form of nausea and vomiting known as hyperemesis gravidarum. Estimates of the incidence of hyperemesis vary from 0.3-1.5% of all live births. Diagnosis is subjective, but the condition is usually described as intractable vomiting leading to fluid, electrolyte and acid base imbalance, nutritional deficiency and weight loss (1) . Hyperemesis gravidarum (HG) is the most common cause of hospitalization in the first half of pregnancy and the second most common cause of antenatal hospitalization during pregnancy. Extreme weight loss is common among women with HG, suggesting that HG is a form of prolonged starvation in pregnancy and that the long-term effects of this condition on women and their offspring warrant further investigation (2) . Measurement of maternal serum alpha fetoprotein (AFP), human chorionic gonadotropin (HCG), and unconjugated estriol (uE3) at the beginning of the second trimester of pregnancy is a well established screening test for trisomies. Association between second trimester screening test parameters and several pregnancy complications have been studied in unselected study populations. Previous studies have described the association of abnormal levels of maternal serum AFP and hCG with a variety of problems and complications of pregnancy, such as preterm delivery, fetal growth retardation, fetal death and severe hypertensive disorders in pregnancy (3) (4) (5) . Serum human chorionic gonadotropin (hCG) and estradiol levels are higher in women with hyperemesis gravidarum (HG) than in unaffected pregnant controls (6) . Concentrations of hCG that are above or below the normal range are associated with poor pregnancy outcomes. It seems that HG and hCG are related and that nutrient restriction during critical periods of embryonic development may ensure production of hCG at optimal levels, protect placental development, and optimize nutrient partitioning between maternal and fetal tissues (7) . The aim of this study was to determine the association between three parameters of second trimester serum screening and preterm labor (PL) and intrauterine growth restriction (IUGR) in patients with HG.
Material and Method
Four hundred twenty nine patients with first to second trimester diagnosis of hyperemesis gravidarum who had been followed for their pregnancies in Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital between January 2005 to December 2009 were included in the study. The study was approved by the local ethics committee. Informed consents were obtained from all the participants. Diagnosis of hyperemesis gravidarum was based on intractable vomiting leading to fluid, electrolyte and acid base imbalance, nutritional deficiency and weight loss. All patients had repeat hospitalizations during pregnancy follow up for hyperemesis. Patients with a history of pregnancy complications (preeclampsia, eclampsia, preterm labor, intrauterine growth restriction etc.) and patients with genetic, structural abnormality, preeclampsia, gestational diabetes, elective cesarean, placental ablation in the present pregnancy were excluded from the study in order to select patients without a risk factor for investigated outcomes. None of the patients had systemic disorders (stomach disease, cholelithiasis, gastroenteritis, chronic gastric disease, multiple pregnancy, etc.). Thyroid function tests were all in normal limits. At the beginning of the second trimester, screening test was performed for each patient between 15 th to 19 th weeks of gestation. After blood serum AFP levels and hCG levels were calculated using the ELISA method; unconjugated estriol was calculated using RIA method for each patients. Patients with increased risk of trisomy and open spina were not excluded from the study. Patients were followed until delivery at monthly intervals. Complications during pregnancies were recorded. Preterm labor was accepted as spontaneous deliveries before 37 weeks of gestation and IUGR was diagnosed in patients with a neonate birth weight smaller than the 10 th percentile of that gestational age. IUGR was also evaluated according to 3 rd and 5 th percentiles. Preterm infants were evaluated for their birth percentiles in order not to miss any IUGR among them.
Statistical analysis
Collected data was entered into SPSS version 11. For group comparisons, analysis of variance and posthoc Tukey test was used. P value smaller than 0.05 was accepted as statistically significant. Binary logistic regression was used to calculate odds ratio. Correlation analysis was used to calculate the degree of associations and ROC analysis was performed for cut off calculation. Regression analysis was used to determine associations.
Result
Means of AFP, hCG, uE3 among groups of complicated and uncomplicated pregnancies and groups divided according to birth weight percentiles: In our study group mean age of patients was 25.4±3.8 years. Mean birth weight was 3180±555 g Mean AFP, uE3, hCG levels in the study group were 1.44±0. 
Associations
Regression analysis revealed that uE3, hCG adjusted AFP; AFP, hCG adjusted uE3; uE3, AFP adjusted hCG were significantly associated with birth weight and IUGR (p<0.001, p<0.001, p<0.05, respectively, Figure 1 ). uE3, AFP adjusted hCG was significantly associated with PL (p<0.05). Hyperemesis gravidarum was first diagnosed at different gestational ages in the study group: at 9 th week (n=22, 5%), 10 th week (n=43:10%), 11 th week (n=51, 12%), 12 th week (n=61, 14%) and 13 th week (n:252.59%). Gestational age of hyperemesis gravidarum diagnosis was positively correlated with birth weight (r=0.288, p=0.001), negatively correlated with PL (r=-0.189, p=0.001) and IUGR (r=-0.181, p=0.001).
ROC analysis
ROC analysis revealed that the AFP level is a significant predictor for IUGR (Area under curve 0.716, p<0.001, Figure 2 ). Cut off value was 1.55 MoM for the AFP level to predict IUGR with 66% sensitivity and 69% specificity. uE3 and hCG levels were not found to be significant predictors for either preterm labor or IUGR in ROC analysis (p>0.005). Odds ratio of AFP>1.55 was 3.73 (95% CI, 1.99-6.98, p<0.001) for IUGR after adjustment for hCG.
Discussion
In our study higher AFP levels were found to be significantly associated with increased IUGR while higher hCG levels were shown to be associated with increased preterm labor rates, higher uE3 levels were associated with both decreased preterm labor and IUGR rates. We expected to observe an association between pregnancy complications caused by hyperemesis and increased hCG levels in HG. Association between hCG and uE3 levels with preterm labor and IUGR were shown in regression analysis, however they are not found to be significant predictors for IUGR or preterm labor in ROC analysis. These results led us to hypothesize that the second trimester screening test can give more information about pregnancy outcome in HG, but only the AFP was useful as a test to predict poor outcome. Patients with different birth weight percentiles in the IUGR group were significantly different in terms of hCG, AFP and uE3 levels. The highest hCG and AFP levels were observed in patients with a birth weight lower than the 3 rd percentile. These results are all thought to be due to increased abnormal placental tissue. Our literature search revealed that, while hyperemesis gravidarum has been found to be associated with high hCG levels (6), its effect on second trimester screening, AFP and unconjugated estriol levels in HG has not been studied. Hyperemesis occurs in 473 of 100.000 live births and is associated with significant changes. Infants of mothers with hyperemesis have lower birth weights and the mothers are more likely to have infants that are small for gestational age (8) . Although elevated maternal serum AFP level usually shows an elevated risk for neural tube defects, they are also related to adverse pregnancy outcomes such as preeclampsia, spontaneous abortion, preterm delivery, low birth weight, IUGR, oligohydramnios, placental abruption and stillbirth (9) (10) (11) (12) , all of which are thought to be associated with abnormal placentation (13) . In our study, a significant association between serum AFP values and IUGR was observed. Patients with high AFP levels and bilateral uterine artery diastolic notch presence, were found to be candidates for pregnancy complications and these groups of patients were advised to be followed up more closely (14) . Multiparameter testing of placental function in the mid-trimester (uterine artery Doppler, placental morphology, AFP and hCG screening) may allow us to identify women with increased risk of developing severe placental insufficiency and pregnancy complications (15) . Increased maternal serum AFP >1.89 MoM were found to be significantly associated with IUGR, pregnancy induced hypertension (PIH) and placental pathology. In our study group, the cut off value was lower, and this might be due to the presence of hyperemesis with higher hCG levels compared to normal pregnancies. Increased beta-hCG >1.69MoM were significantly associated with PIH and IUGR. It was concluded that the triple test can be used not only for the detection of fetal chromosomal and neural tube defect abnormalities but also for the detection of high-risk pregnancies (16) . Recently published data has shown that serum unconjugated estriol, AFP or hCG values in triple test results may be associated with development of oligohydramnios, gestational diabetes and macrosomia in women with healthy and normal appearing fetuses (17) . Despite the increase in prematurity and low birth weight, unexplained raised levels of AFP were not associated with an increase in perinatal mortality (18) . A retrospective trial found that increased antenatal surveillance for women with unexplained elevated AFP did not provide any benefit for detection of adverse events (19) . Women with elevated second-trimester hCG values have been reported to have increased risks for preeclampsia, IUGR, small for gestational age (SGA) infants, preterm delivery, spontaneous abortion, stillbirth and placental abnormalities (9, 12, (20) (21) (22) . However, Ashour et al. (23) suggested that the utility of hCG level as a screening test for preeclampsia was limited. Besides, the relationship between obstetric complications and elevated hCG levels was not confirmed in two other studies (10, 24) . In another study, preterm delivery, preeclampsia and large for gestational age were found to be associated with only hCG levels of 3 MoM and the authors concluded that increased fetal surveillance is not warranted with lower values (25) . Consistent with our results, a low uE3 level was suggested as an independent risk factor for adverse pregnancy outcome and is particularly associated with preeclampsia, in conjunction with IUGR, SGA, oligohydramnios, preterm delivery and stillbirth (9, 12, 26) . In a meta-analysis by Morris et al. Down's serum screening analytes were found to have low predictive accuracy for pre-eclampsia and small for gestational age. The study concluded that they may be a useful means of risk assessment or of use in prediction when combined with other tests (27) . This study was conducted specifically on patients with HG, and in our literature review we have not encountered a similar study. The relatively small sample size is a limitation of this study. Our study suggests that the AFP level of the second trimester screening test of higher than 1.55 MoM is significantly associated with IUGR in HG. The highest hCG and AFP levels were seen in patients with birth weight below the 3 rd percentile. Further studies are needed to establish the predictors of poor pregnancy outcome in HG. 
